Bausch Health Companies | VRX - Trade Creditors

Stock Price
7.11
Daily Change
0.23 3.34%
Monthly
-16.45%
Yearly
-29.04%
Q1 Forecast
6.65

Bausch Health Companies reported $600M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Amgen USD 20.89B 1.25B Dec/2025
ANI Pharmaceuticals USD 62.58M 7.21M Dec/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Bausch Health Companies USD 600M 16M Dec/2025
Biogen USD 432M 18.9M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Corcept Therapeutics USD 40.44M 6M Dec/2025
Danaher USD 1.84B 147M Dec/2025
Drreddys Laboratories INR 454.04M 854K Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Novo Nordisk DKK 19.76B 4.15B Dec/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Phibro Animal Health USD 133.3M 2.7M Dec/2025
Prestige Brands USD 42.95M 1.02M Dec/2025
Supernus Pharmaceuticals USD 107.8M 813K Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Zoetis USD 487M 77M Dec/2025